Disc Medicine, Inc. (IRON)
68.42
-0.07
(-0.10%)
USD |
NASDAQ |
Sep 22, 16:00
68.42
0.00 (0.00%)
After-Hours: 20:00
Disc Medicine Shareholders Equity (Quarterly) : 644.16M for June 30, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 644.16M |
| March 31, 2026 | 688.43M |
| December 31, 2025 | 739.83M |
| September 30, 2025 | 573.39M |
| June 30, 2025 | 614.16M |
| March 31, 2025 | 660.36M |
| December 31, 2024 | 443.59M |
| September 30, 2024 | 467.96M |
| June 30, 2024 | 488.83M |
| March 31, 2024 | 338.07M |
| December 31, 2023 | 345.12M |
| September 30, 2023 | 358.97M |
| June 30, 2023 | 371.22M |
| Date | Value |
|---|---|
| March 31, 2023 | 232.86M |
| December 31, 2022 | 176.60M |
| September 30, 2022 | 104.57M |
| June 30, 2022 | 106.90M |
| March 31, 2022 | 111.61M |
| December 31, 2021 | 77.65M |
| September 30, 2021 | 140.86M |
| June 30, 2021 | 157.68M |
| March 31, 2021 | 171.16M |
| December 31, 2020 | -21.86M |
| September 30, 2020 | 117.58M |
| June 30, 2020 | 0.0235M |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Recursion Pharmaceuticals, Inc. | 915.00M |
| Agenus, Inc. | -199.08M |
| Amgen, Inc. | 11.69B |
| Anika Therapeutics, Inc. | 137.28M |
| BioCryst Pharmaceuticals, Inc. | -454.29M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 735.07M |
| Total Liabilities (Quarterly) | 90.91M |
| Debt to Equity Ratio | 0.0945 |
| Current Ratio | 24.14 |
| Net Debt Paydown Yield | -0.22% |